Cancer News and Research

Latest Cancer News and Research

New preclinical data from Baxter's BAX 499 hemophilia study presented at ISTH

Baxter International Inc. announced today that new data from a series of studies on BAX 499, an investigational compound for potential subcutaneous hemophilia therapy, were presented this week during the 23rd annual congress of the International Society on Thrombosis and Haemostasis (ISTH) in Kyoto, Japan.

From Baxter International Inc. 27 Jul 2011

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a pinball machine.

27 Jul 2011

Lipofilling found safe after breast cancer surgery

Preliminary experience suggests that lipofilling—using fat from elsewhere in the patient's body for contouring of the breasts—is a safe procedure for women who have undergone breast cancer surgery, reports a study in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

27 Jul 2011

Gut microflora may influence obesity treatments

Obesity in the United States is reaching ever more alarming proportions, posing a severe menace to public health and exacerbating a crisis in health care costs both domestically and worldwide.

27 Jul 2011

Innovative MD leadership program for medical students

The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.

27 Jul 2011

High-dose vitamin D reduces musculoskeletal pain in breast cancer patients

High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.

27 Jul 2011

Lipid-based nanocarrier can improve cancer treatments

Scientists seeking to improve cancer treatments have created a tiny drug transporter that maximizes its ability to silence damaging genes by finding the equivalent of an expressway into a target cell.

27 Jul 2011

Four-year study to test effectiveness of WHO Safe Childbirth program

Harvard School of Public Health (HSPH) has been awarded a $14.1 million, four-year grant from the Bill & Melinda Gates Foundation to test the effectiveness of an innovative checklist-based childbirth safety program in reducing deaths and improving outcomes of mothers and infants in 120 hospitals in India.

27 Jul 2011

Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

Aeterna Zentaris Inc. today announced completion of its Phase 3 study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency (AGHD).

27 Jul 2011

Roundup: Md. to release cancer control plan; funding cut at Texas mental health centers

Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.

27 Jul 2011

Men's chances of getting bowel cancer have doubled in Great Britain

Men's chances of getting bowel cancer in Great Britain have doubled since the mid 70s - according to new figures released today by Cancer Research UK.

27 Jul 2011

FDA grants Orphan Drug Designation for Diffusion's TSC to treat glioblastoma multiforme

Diffusion Pharmaceuticals LLC announced today that trans sodium crocetinate (TSC), the company's lead drug candidate, has been granted an Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of primary brain cancer, also known as glioblastoma multiforme or GBM.

27 Jul 2011

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Otsuka Canada Pharmaceutical Inc. (OCPI) announced today that Health Canada has issued a notice of compliance for SAMSCA (tolvaptan), the first medicine approved in Canada for the treatment of hyponatremia.

27 Jul 2011

Lack of genetic screening for cancers

In a new study published Monday in the journal Cancer, it was noted that while genetic testing to check if a woman has the BRCA1 or BRCA2 mutations can be a useful tool for preventing breast cancer and ovarian cancer in some cases, many doctors are not referring patients.

26 Jul 2011

Racal differences in breast cancer survival: Study

Black women are more likely to die from breast cancer than white women with obesity considered a significant factor. But a new study shows that that the cause of the difference does not lie in obesity alone. As a group, black women in the U.S. tend to be heavier than whites and researchers had thought that might explain why only 78 percent survive five years after diagnosis, compared to 90 percent of white women.

26 Jul 2011

Hormone therapy may be hazardous in men with pre-existing heart conditions

Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology·Biology·Physics, the official scientific journal of ASTRO.

26 Jul 2011

Volunteers needed in worldwide study to help people breathe easier

Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.

26 Jul 2011

Abbott announces research confirming presence of lutein in key regions of the infant brain

Preliminary new research demonstrates for the first time that lutein, an important phytonutrient (plant-based nutrient) that supports eye health, is the predominant carotenoid present in key areas of the infant brain, including areas that regulate overall brain function, cognition, vision, hearing and speech. This new research, supported by Abbott, was presented by Elizabeth Johnson, PhD, a scientist in the Carotenoids and Health Laboratory at Tufts University, at the 16th International Symposium on Carotenoids, in Krakow, Poland.

26 Jul 2011

Smoke-free ground swell increasing

The 2011 results of the Heart Foundation’s smoke-free policy survey reveal that almost 60 per cent of NSW Councils have implemented policy to restrict tobacco use in outdoor areas.

26 Jul 2011

Researchers reveal how photolyase can repair sunburn

Researchers who have been working for nearly a decade to piece together the process by which an enzyme repairs sun-damaged DNA have finally witnessed the entire process in full detail in the laboratory.

26 Jul 2011